BKG-PHARMA ApS: Financial statements 2012
CVR: 27959350
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
BKG-PHARMA ApS (CVR 27959350) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 836,978 and a net result of DKK 535,020. Equity in the 2012 report amounted to DKK 13,756,552. The solvency ratio was 90.8%.
- Gross Profit
- DKK 836,978
- Profit/Loss
- DKK 535,020
- Equity
- DKK 13,756,552
- Total Assets
- DKK 15,146,246
Official annual report
Keep an eye on BKG-PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 31, 2012, Frank Knudsen has left the board of directors of BKG-PHARMA ApS.
About BKG-PHARMA ApS
BKG-PHARMA ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2004. The company has been dissolved on 27 December 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2018). In 2016, the company reported a gross profit of DKK -616,406 and a net result of DKK -18,025,433 compared with DKK -94,523 the year before. Equity in the 2016 report amounted to DKK -2,682,678.